Gastroesophageal Reflux Disease (GERD) Device Market

Gastroesophageal Reflux Disease (GERD) Device Market Outlook

Around USD 1207.3 million is projected to be the value of global sales of gastroesophageal reflux disease (GERD) device in 2024. By 2034, the gastroesophageal reflux disease (GERD) device market is anticipated to advance at a 3.6% CAGR and surpass a valuation of USD 1719.5 million. The increasing prevalence of GERD and the development of less invasive treatment options are projected to contribute to the gastroesophageal reflux disease device market's steady rise.

Technological advancements such as endoscopic therapy and magnetic sphincter augmentation devices are becoming a growing trend since they provide efficient substitutes for conventional surgical and pharmaceutical methods. The gastroesophageal reflux disease (GERD) device market is expanding due to patients and healthcare professionals becoming conscious of the advantages of these devices, which include quicker recovery times and enhanced quality of life.

Attributes	Details
Market Value for 2024	USD 1207.3 million
Market Value for 2034	USD 1719.5 million
Market CAGR from 2024 to 2034	3.6%

Growth Avenues in the Gastroesophageal Reflux Disease (GERD) Device Market

• Due to parameters like patient preference, cost-effectiveness, and convenience, ambulatory care and outpatient operations are progressively prevalent. This trend is particularly suited for gastroesophageal reflux disease (GERD) devices utilized in minimally invasive treatments or outpatient settings.
• Pressure is on healthcare systems to reduce costs and enhance patient outcomes. In the long run, gastroesophageal reflux disease (GERD) devices that provide long-term symptom alleviation and lessen the requirement for continued medication or repeated procedures are likely to save money.
• Patients and healthcare professionals are now more aware of GERD and its possible consequences, which has resulted in earlier diagnosis and treatment commencement. This facilitates the adoption of gastroesophageal reflux disease devices by creating a favorable atmosphere.

Attributes	Details
Market Value for 2019	USD 1001 million
Market Value for 2023	USD 1213.4 million
Market CAGR from 2019 to 2023	3.9%

Impediments Impacting the Gastroesophageal Reflux Disease (GERD) Device Industry

• Many people with GERD symptoms are unaware that they have the illness, which results in underdiagnosis and undertreatment. Insufficient knowledge among patients and medical professionals impedes the adoption of GERD devices.
• GERD device reimbursement policies is complicated and varied amongst healthcare systems. Patient access and healthcare provider uptake are hampered by limited coverage and reimbursement choices.
• New GERD devices cannot reach the market sooner due to drawn-out approval processes caused by strict regulatory regulations and the demand for extensive clinical data. This acts as an impediment to gastroesophageal reflux disease (GERD) device market expansion.

Category-wise Outlook

The segmented study of the gastroesophageal reflux disease (GERD) device market is detailed in the part below. Extensive research demonstrates that diagnostic procedures are at the forefront of procedural innovations, with esophagoscopes and gastroscopes commanding the product segment.

This comprehensive analysis sheds light on the constantly shifting landscape of GERD management, identifying major trends and in the gastroesophageal reflux disease device market.

The Leading Role of Esophagoscopes and Gastroscopes in GERD Device Market

Segment	Esophagoscopes and Gastroscopes
Share (2024)	90%

• Esophagoscopy and gastroscopy segments are crucial diagnostic instruments that provide exact vision to detect and manage GERD accurately.
• The business need for effective diagnostic procedures drives sales of gastroscopes and esophagoscopes in the gastroesophageal reflux disease (GERD) device market.
• As a crucial component of the diagnostic toolkit, gastroscopes and esophagoscopes support market leadership by meeting the increasing demand for sophisticated GERD evaluation.

Diagnostic Procedures Shaping GERD Treatment Paradigms

Segment	Diagnostic Procedures
Share (2024)	68%

• Healthcare providers' need is encouraged by the demand for GERD device diagnostic techniques, which provide crucial insights for customized treatment programs.
• Diagnostic technology investments are drawing investors and healthcare providers as they align with the increased emphasis on value-based healthcare.
• The leading position in gastroesophageal reflux disease (GERD) device sales of the diagnostic procedures category highlights its critical function in determining the treatment options available for GERD.

Country-wise Analysis

The GERD device market can be observed in the subsequent tables, which focus on the leading regions in North America, Europe, and Asia Pacific. A comprehensive evaluation demonstrates that Asia Pacific has enormous market opportunities for gastroesophageal reflux disease device.

Opportunities in the Asia Pacific Gastroesophageal Reflux Disease (GERD) Device Industry

Countries	CAGR (2024 to 2034)
India	5.2%
Thailand	5.0%
Malaysia	4.6%
Indonesia	3.4%

India Industry Outlook

• The gastroesophageal reflux disease (GERD) device industry in India likely expand even more due to government attempts to encourage medical travel and draw in foreign investment in the medical field.
• There is an increasing need for novel and reasonably priced devices in India as the number of GERD cases being identified and treated rises.

Thailand Industry Outlook

• As Thailand grows in popularity as a destination for medical treatments, the country's growing medical tourism industry is fueling the demand for gastroesophageal reflux disease (GERD) devices.
• The adoption of GERD devices in Thailand is boosted by a growing patient and healthcare professional awareness of GERD and its treatment alternatives.

Malaysia Industry Outlook

• Adopting cutting-edge medical treatments and technologies governs the demand for GERD devices in Malaysia's healthcare industry.
• Malaysian individuals' and healthcare professionals' growing awareness of GERD and its repercussions surges the GERD device market.

Indonesia Industry Outlook

• The increased prevalence of GERD is caused by changes in living choices and rising disposable income, which is propelling the gastroesophageal reflux disease device market in Indonesia.
• The adoption of GERD devices is increasing in Indonesia due to patients' and healthcare providers' growing knowledge of GERD and available treatments.

Insights into Sales Performance of Gastroesophageal Reflux Disease (GERD) Device in North America

Countries	CAGR (2024 to 2034)
United States	2.6%
Canada	2.9%

United States Industry Outlook

• The gastroesophageal reflux disease (GERD) device market dynamics are significantly shaped by health insurance coverage and reimbursement policies in the United States, which affects patient accessibility and affordability.
• The emphasis on enhancing quality of life and patient preference for non-surgical alternatives are important reasons propelling the adoption of GERD devices in the United States.

Canada Industry Outlook

• A wider adoption of GERD devices is supported by the Canadian healthcare system's emphasis on universal access to medical services, which guarantees fair availability for patients from various demographic backgrounds.
• The introduction and adoption of gastroesophageal reflux disease devices in Canada are significantly shaped by regulatory frameworks and approval procedures prioritizing safety and efficacy.

Opportunities for Gastroesophageal Reflux Disease (GERD) Device Market in Europe

Countries	CAGR (2024 to 2034)
Germany	1.9%
United Kingdom	1.6%
France	2.3%
Italy	2.0%
Spain	2.9%

Germany Industry Outlook

• The demand for GERD devices is expanding in Germany due to proactive healthcare activities and increased awareness.
• Significant industry participants and a strong regulatory environment bolster German gastroesophageal reflux disease (GERD) device sales.
• The Germany gastroesophageal reflux disease (GERD) device market is growing due to rising GERD prevalence and strong patient acceptance of minimally invasive procedures.

United Kingdom Industry Outlook

• Growing rates of GERD are encouraging market expansion in the United Kingdom due to the adoption of new medical technology.
• Proactive health education campaigns raise awareness and encourage early intervention, influencing the United Kingdom's sales of gastroesophageal reflux disease (GERD) device.

France Industry Outlook

• The growing awareness of GERD by the general public and healthcare professionals contributes to the French demand for modern GERD devices.
• The gastroesophageal reflux disease device market in France benefits from a rising emphasis on customized treatment solutions and a trend toward personalized medicine.

Italy Industry Outlook

• Adopting telemedicine and digital health solutions in Italy has increased gastroesophageal reflux disease (GERD) device accessibility and usage.
• The growing demand for GERD devices is fueled by Italy's preventative care-focused healthcare system, which presents opportunities for market expansion of gastroesophageal reflux disease (GERD) device.

Spain Industry Outlook

• A cultural trend in Spain toward proactive health management and a growing acceptance of innovative medical technologies benefit the GERD device market.
• The gastroesophageal reflux disease device market in Spain demonstrates an increasing need for individualized treatment plans, motivated by a better knowledge of each patient's requirements.

Competitive Analysis

Several prominent gastroesophageal reflux disease device vendors are vying for market share in the highly competitive atmosphere of the industry.

Notable gastroesophageal reflux disease device manufacturers influencing the direction of the business are Olympus Corporation, Pentax Medical, KARL STORZ SE & Co KG, Medtronic Plc, Fujifilm Holdings Corporation, EndoGastric Solutions, Medigus Ltd., and Diversatek Inc. By addressing the difficulties associated with managing GERD, these gastroesophageal reflux disease device businesses offer a variety of technological expertise, creating a competitive atmosphere centered on enhancing patient outcomes and expanding available treatment options.

Olympus Corporation, Pentax Medical, KARL STORZ SE, and Co KG are improving GERD device technology. This gastroesophageal reflux disease (GERD) device providers are known for their dedication to quality and innovation. Medtronic Plc uses its broad healthcare portfolio to provide comprehensive solutions for managing GERD, while Fujifilm Holdings Corporation contributes its imaging expertise to improve diagnostic capabilities.

By providing specialized tools and methods that address particular patient demands and broaden the range of available treatments, EndoGastric Solutions, Medigus Ltd., and Diversatek Inc. make contributions.

Continuous innovation and development in GERD management tactics are expected as these major gastroesophageal reflux disease device vendors cooperate and compete. These gastroesophageal reflux disease device suppliers are essential in influencing the direction of GERD therapy and enhancing the lives of those impacted by the disease by emphasizing patient-centric solutions and technical innovations.

Notable Strides

Company	Details
Wockhardt Ltd.	Wockhardt Ltd. acquired its authorized generic versions of several over-the-counter medications from Glenmark Pharmaceuticals Ltd. in June 2022. The approved abbreviated new drug applications for famotidine tablets, which are used to treat and prevent stomach and intestinal ulcers, as well as treatment drug Lansoprazole delayed-release capsules USP, 15 mg, are among the medications included in the acquisition by the company's fully owned subsidiary Glenmark Pharmaceuticals Inc, USA.
Zydus Lifesciences	The FDA approved Zydus Lifesciences' 20 mg and 40 mg formulations of metronidazole tablets for sale in June 2022. As a histamine H2 receptor blocker, famotidine lowers stomach acid production. The medication is intended to treat and prevent acid reflux disease (GERD) as well as other related symptoms.
Peptest	Peptest, a non-invasive radiofrequency device designed by RD Biomed for the diagnosis of reflux devices, was approved by China. This device detects pepsin in saliva samples and helps with the overall treatment of reflux-related devices.
EsophyX Z	An improved and more recent version of the EsophyX device is the EsophyX Z gastroesophageal reflux disease device, used to perform transoral incisionless fundoplication.

Prominent Gastroesophageal Reflux Disease (GERD) Device Vendors

• Olympus Corporation
• Pentax Medical
• KARL STORZ SE and Co KG.
• Medtronic Plc
• Fujifilm Holdings Corporation
• EndoGastric Solutions
• Medigus Ltd.
• Diversatek Inc.

Key Coverage in GERD Device Market Report

• Adjacent Study on GERD Device Market, Gastroesophageal Reflux Disease Therapeutics Market, and Medical Device Technologies Market
• Market Trends Escalating GERD Device Sales
• Thailand’s Opportunity to Become a Global Frontrunner in Gastroesophageal Reflux Disease (GERD) Device
• Demand for Gastroesophageal Reflux Disease (GERD) Device in India
• Strategies for Gastroesophageal Reflux Disease (GERD) Device Vendors
• Competitive Analysis of Leading Gastroesophageal Reflux Disease (GERD) Device Providers with Focus on Peptest, EsophyX Z, and Others.

Key Segments

By Product:

• Diagnostic Devices
• Manometry Systems
• PH Monitoring Systems
• Esophagoscopes and Gastroscopes
• Treatment Devices
• Ultrasonic Surgical Endostaplers
• Fundoplication Devices
• Sphincter Augmentation Devices
• Radiofrequency Ablation Devices

By Procedure:

• Diagnostic Procedures
• Fundoplication Procedures
• Radiofrequency Thermal Ablation
• Magnetic Sphincter Augmentation

By End User:

• Hospitals
• Diagnostic Centers
• Ambulatory Surgical Centers

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia and Pacific
• Middle East and Africa (MEA)

Frequently Asked Questions

What is Current Gastroesophageal Reflux Disease (GERD) Device Market Valuation?

The GERD device market to secure a valuation USD 1207.3 million in 2024.

How Big Can the Gastroesophageal Reflux Disease (GERD) Device Market Be by 2034?

The GERD device market is estimated to attain USD 1719.5 million by 2034.

What is the Growth Potential of the Gastroesophageal Reflux Disease (GERD) Device Market?

Through 2034, the GERD device market is anticipated to evolve at a 3.6% CAGR.

What Was the Historical Outlook of The Gastroesophageal Reflux Disease (GERD) Device Market?

From 2019 to 2023, the gastroesophageal reflux disease (GERD) device market registered a 3.9% CAGR.

Which Product Segment to Dominate in the Gastroesophageal Reflux Disease (GERD) Device Market?

The esophagoscopes and gastroscopes sector is set to achieve a market share of 90% in 2024.

Which Procedure Segment to Lead the Gastroesophageal Reflux Disease (GERD) Device Market?

A 68% market share is expected for the diagnostic procedures sector in 2024.